Effect of silencing HOXA5 gene expression using RNA interference on cell cycle and apoptosis in Jurkat cells

Huang,Hui-Ping; Liu,Wen-Jun; Guo,Qu-Lian; Bai,Yong-Qi

doi:10.3892/ijmm.2016.2480

Effect of silencing HOXA5 gene expression using RNA interference on cell cycle and apoptosis in Jurkat cells

Authors:
- Hui-Ping Huang
- Wen-Jun Liu
- Qu-Lian Guo
- Yong-Qi Bai
View Affiliations

Affiliations: Department of Pediatrics, The First Affiliated Hospital of Sichuan Medical University, Luzhou, Sichuan 646000, P.R. China
Published online on: February 4, 2016 https://doi.org/10.3892/ijmm.2016.2480
Pages: 669-678
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acute lymphocytic leukemia (ALL) is a common malignant tumor with a high morbidity rate among children, accounting for approximately 80% of leukemia cases. Although there have been improvements in the treatment of patients frequent relapse lead to a poor prognosis. The aim of the present study was to determine whether HOXA5 may be used as a target for gene therapy in leukemia in order to provide a new treatment. Mononuclear cells were extracted from the bone marrow according to the clinical research aims. After testing for ALL in the acute stage, the relative mRNA and protein expression of HOXA5 was detected in the ALL remission groups (n=25 cases per group) and the control group [n=20 cases, immune thrombocytopenia (ITP)]. Gene silencing by RNA interference (RNAi) was used to investigate the effect of silencing HOXA5 after small interfering RNA (siRNA) transfection to Jurkat cells. The HOXA5-specific siRNA was transfected to Jurkat cells using lipofectamine. The experiment was divided into the experimental group (liposomal transfection of HOXA5 targeting siRNA), the negative control group (liposomal transfection of cells with negative control siRNA) and the control group (plus an equal amount of cells and culture media only). Western blotting and quantitative fluorescent polymerase chain reaction (QF‑PCR) were used to detect the relative HOXA5 mRNA expression and protein distribution in each cell group. Cell distribution in the cell cycle and the rate of cells undergoing apoptosis were determined using flow cytometry. The expression of HOXA5 at the mRNA and protein levels in the acute phase of ALL was significantly higher than that in ALL in the remission and control groups. In cells transfected with HOXA5-specific siRNA, the expression of HOXA5 at the mRNA and protein levels decreased significantly (P<0.05). The distribution of cells in the cell cycle was also altered. Specifically, more cells were present in the G0/G1 phase compared to the S phase (P<0.05). In addition, the apoptotic rate was significantly higher in cells transfected with HOXA5‑specific siRNA (P<0.05). In conclusion, high expression levels of HOXA5 mRNA and protein in children with ALL indicate that HOXA5 is closely associated with childhood ALL. In addition, HOXA5-specific siRNA effectively silences HOXA5 gene expression and induces apoptosis and cell-cycle arrest in Jurkat cells, thus inhibiting cell proliferation.

View Figures

View References

1	Ceppi F, Antillon F, Pacheco C, Sullivan CE, Lam CG, Howard SC and Conter V: Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries. Expert Rev Hematol. May 26–2015.Epub ahead of print. View Article : Google Scholar
2	Lo-Coco F, Fouad TM and Ramadan SM: Acute leukemia in women. Womens Health (Lond Engl). 6:239–249. 2010. View Article : Google Scholar
3	Pui CH: Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc. 109:777–787. 2010. View Article : Google Scholar : PubMed/NCBI
4	Strathdee G, Holyoake TL, Sim A, Parker A, Oscier DG, Melo JV, Meyer S, Eden T, Dickinson AM, Mountford JC, Jorgensen HG, Soutar R and Brown R: Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res. 13:5048–5055. 2007. View Article : Google Scholar : PubMed/NCBI
5	De Braekeleer E, Douet-Guilbert N, Basinko A, Le Bris MJ, Morel F and De Braekeleer M: Hox gene dysregulation in acute myeloid leukemia. Future Oncol. 10:475–495. 2014. View Article : Google Scholar : PubMed/NCBI
6	Lu TT and Liu W: Studies on the relationship between HOX genes and leukemia. J Pediatr Hematol Oncol. 18:1421452013.
7	Delval S, Taminiau A, Lamy J, Lallemand C, Gilles C, Noël A and Rezsohazy R: The Pbx interaction motif of Hoxa1 is essential for its oncogenic activity. PLoS One. 6:e252472011. View Article : Google Scholar : PubMed/NCBI
8	Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L and Zhang Y: Leukaemic transformation by CALMAF10 involves upregulation of HOXA5 by hDOT1L. Nat Cell Biol. 8:1017–1024. 2006. View Article : Google Scholar : PubMed/NCBI
9	Bach C, Buhl S, Mueller D, García-Cuéllar MP, Maethner E and Slany RK: Leukemogenic transformation by HOXA cluster genes. Blood. 115:2910–2918. 2010. View Article : Google Scholar : PubMed/NCBI
10	Boutter J, Huang Y, Marovca B, Vonderheit A, Grotzer MA, Eckert C, Cario G, Wollscheid B, Horvath P, Bornhauser BC and Bourquin JP: Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support. Oncotarget. 5:11501–11512. 2014. View Article : Google Scholar : PubMed/NCBI
11	Landry B, Valencia-Serna J, Gul-Uludag H, Jiang X, Janowska-Wieczorek A, Brandwein J and Uludag H: Progress in RNAi-mediated molecular therapy of acute and chromic myeloid leukemia. Mol Ther Nucleic Acids. 4:e2402015. View Article : Google Scholar
12	Olivieri D, Sykora MM, Sachidanandam R, Mechtler K and Brennecke J: An in vivo RNAi assay identifies major genetic and cellular requirements for primary piRNA biogenesis in Drosophila. EMBO J. 29:3301–3317. 2010. View Article : Google Scholar : PubMed/NCBI
13	China Medical Sciences Branch of Hematology Group: Editorial Committee Member of Chinese Journal of Pediatrics. Diagnosis and treatment for children with acute lymphoblastic leukemia (Third Amendment Bill). Zhonghua Er Ke Za Zhi. 44:392–395. 2006.In Chinese.
14	Qian X and Wen-jun L: Platelet changes in acute leukemia. Cell Biochem Biophys. 67:1473–1479. 2013. View Article : Google Scholar : PubMed/NCBI
15	Jiang Q and Liu WJ: Relationship between the HOX gene family and the acute myeloid leukemia-review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 21:1340–1344. 2013.In Chinese. PubMed/NCBI
16	Wen-jun L, Qu-lian G, Hong-ying C, Yan Z and Mei-Xian H: Studies on HOXB4 expression during differentiation of human cytomegalovirus-infected hematopoietic stem cells into lymphocyte and erythrocyte progenitor cells. Cell Biochem Biophys. 63:133–141. 2012. View Article : Google Scholar : PubMed/NCBI
17	Liu WJ, Huang MX, Guo QL, Chen JH and Shi H: Effect of human cytomegalovirus infection on the expression of Hoxb2 and Hoxb4 genes in the developmental process of cord blood erythroid progenitors. Mol Med Rep. 4:1307–1311. 2011.PubMed/NCBI
18	Liu WJ1, Jiang NJ, Guo QL and Xu Q: ATRA and As₂O₃ regulate differentiation of human hematopoietic stem cells into granulocyte progenitor via alteration of Hoxb8 expression. Eur Rev Med Pharmacol Sci. 19:1055–1062. 2015.
19	Shah N and Sukumar S: The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 10:361–371. 2010. View Article : Google Scholar : PubMed/NCBI
20	Jiang N and Liu W: Role of HOX gene in occurrence of leukemia and study progress. J Appl Clin Pediatr. 27:215–217. 2012.In Chinese.
21	Marschalek R: Mechanisms of leukemogenesis by MLL fusion proteins. Br J Haematol. 152:141–154. 2011. View Article : Google Scholar
22	Yang D, Zhang X, Dong Y, Liu X, Wang T, Wang X, Geng Y, Fang S, Zheng Y, Chen X, et al: Enforced expression of Hoxa5 in haematopoietic stem cells leads to aberrant erythropoiesis in vivo. Cell Cycle. 14:612–620. 2015. View Article : Google Scholar : PubMed/NCBI
23	Kim SY, Hwang SH, Song EJ, Shin HJ, Jung JS and Lee EY: Level of HOXA5 hypermethylation in acute myeloid leukemia is associated with short-term outcome. Korean J Lab Med. 30:469–473. 2010. View Article : Google Scholar : PubMed/NCBI
24	Zhang ML, Nie FQ, Sun M, Xia R, Xie M, Lu KH and Li W: HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer. Tumour Biol. 36:3521–3531. 2015. View Article : Google Scholar : PubMed/NCBI
25	Fujita Y, Kuwano K and Ochiya T: Development of small RNA delivery systems for lung cancer therapy. Int J Mol Sci. 16:5254–5270. 2015. View Article : Google Scholar : PubMed/NCBI
26	Teng Z and Liu W: The research progress of RNA interference targeting leukemia HOXA genes. Chin J Pract Pediatr. 30:396–399. 2015.
27	Moore MA, Dorn DC, Schuringa JJ, Chung KY and Morrone G: Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp Hematol. 35(Suppl 1): 105–116. 2007. View Article : Google Scholar : PubMed/NCBI
28	Liu XH, Lu KH, Wang KM, Sun M, Zhang EB, Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer. 12:348–360. 2012. View Article : Google Scholar : PubMed/NCBI
29	Wang Y, Liu XR, Tan YF and Yin XC: Effects of CXCR4 silence induced by RNA interference on cell cycle distribution and apoptosis of Jurkat cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 18:625–628. 2010.In Chinese. PubMed/NCBI
30	Crnkovic-Mertens I, Hoppe-Seyler F and Butz K: Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene. 22:8330–8336. 2003. View Article : Google Scholar : PubMed/NCBI
31	Wu H, Lin H, Zhu Y, Gu C, Ye Z and Zhang M: Establishment of Jurkat Cell Lines with Knockdown of BIRC7 Gene. J Sun Yat-Sen Univ. 29:139–143. 2008.In Chinese.
32	Zhang YJ, Jia XH, Li JC and Xu YH: Effect of HOXA10 gene silenced by shRNA on proliferation and apoptosis of U937 cell line. Zhongguo Dang Dai Er Ke Za Zhi. 14:785–791. 2012.In Chinese. PubMed/NCBI
33	Fan W, Jia X, Li J, Tang S and Zhu S: Effects of RNA interference and low dose cytarabine on proliferation and apoptosis of K562 cells. J Appl Clin Pediatr. 27:1177–1180. 2012.
34	Chen H, Chung S and Sukumar S: HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol. 24:924–935. 2004. View Article : Google Scholar : PubMed/NCBI